medical research

A new technique for delivering radiation to glioblastoma brain tumors may allow doctors to use much higher doses while preserving healthy brain tissue. UT Health San Antonio's Andrew Brenner, MD, PhD, says this may give patients more time.

UT Health San Antonio researchers have teased out why some lipids spike in the brains of people with Alzheimer's disease and what that may mean for cognitive function, revealing a new target for potential treatments.

For many chronic migraines and brutal “cluster” headaches are inescapable. The new book The Headache looks for answers about why so many suffer from the jackhammer pounding attacks on the brain. From cutting-edge clinics to experimental treatments, we hear about the search for relief.

A San Antonio scientist thinks of the protein that drives most prostate cancers as a machine, and pioneers a method to visualize it for the first time. This could lead to much better treatments and, someday, prevention.

A San Antonio researcher is working on a drug that could treat Ewing sarcoma and rhabdomyosarcoma without lifelong side effects. It would be the first new treatment option for these childhood cancers in 30 years.

Occupational therapy can help people with mental illness resume meaningful activities in their lives and create strategies that will improve their overall health. A San Antonio OT has developed a program she hopes will help people with a mental illness and type 2 diabetes achieve better control over their disease.

A cutting-edge technology and an exciting recent hire hint at exciting developments in the future of precision medicine in the diagnosis and treatment of Alzheimer's disease.

A medication that appears to preserve brain function after a stroke will soon go into human trials. The San Antonio researcher who discovered the medication's potential more than two decades ago is still leading the team.

Patients have been leaving the United States to try psychedelic therapies to treat their depression, PTSD, traumatic brain injuries, and substance use disorders. With so many patients finding relief, why do psychedelic therapies mostly remain illegal in the U.S., and how do psychedelics actually work?

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how to increase uptake. mRNA vaccine research may be on the chopping block, too.